The Pseudomonas aeruginosa ribonuclease Ribocin cleaves eukaryotic ribosomes at helix 69 to inhibit host translation
PLOS Biology · 2026
DOI: 10.1371/journal.pbio.3003790 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, 2026. Verfasst von Alejandro Vasquez-Rifo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Program in Molecular Medicine, UMass Chan Medical School, Worcester, Massachusetts, United States of America. Hauptthemen laut MEDLINE: Ribosomes, Pseudomonas aeruginosa, Protein Biosynthesis, Bacterial Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health, Pew Charitable Trusts.
Abstract (Originalsprache)
Pseudomonas aeruginosa employs host translation inhibition as a virulence-enhancing strategy. We previously showed that the bacterium induces cleavage of Caenorhabditis elegans large ribosomal RNA at helix 69 (H69), part of a central intersubunit bridge and the ribosomal decoding center. In this study, we demonstrate that a previously uncharacterized ribonuclease, Ribocin, is necessary and sufficient for H69 cleavage. Recombinant Ribocin cuts H69 in worm and mammalian ribosomes, indicating that H69 cleavage by P. aeruginosa is phylogenetically conserved. In worms, mammalian cells, and rabbit reticulocyte lysates, H69 cleavage results in translation inhibition. Furthermore, Ribocin contributes to bacterial virulence toward C. elegans , triggers a major host response to translation inhibition, and operates in parallel with Exotoxin A-mediated translation inhibition. These findings unveil the first known nuclease that cleaves eukaryotic ribosomes at H69 and expand the understanding of host translation-inhibition by establishing targeted rRNA cleavage as a mechanism of host attack.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Program in Molecular Medicine, UMass Chan Medical School, Worcester, Massachusetts, United States of America.
- RNA Therapeutics Institute, UMass Chan Medical School, Worcester, Massachusetts, United States of America.
- Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
- Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, California, United States of America.
ORCID-Profile: Alejandro Vasquez-Rifo, Gabriel Demo
Förderung
- National Institutes of Health
- Pew Charitable Trusts
Zitieren
APA
Vasquez-Rifo, A., Susorov, D., Sholi, E. H., Demo, G., Jami, Y., Sha, J., Wohlschlegel, J. A., Korostelev, A., & Ambros, V. (2026). The Pseudomonas aeruginosa ribonuclease Ribocin cleaves eukaryotic ribosomes at helix 69 to inhibit host translation. PLOS Biology. https://doi.org/10.1371/journal.pbio.3003790
Vancouver
Vasquez-Rifo A, Susorov D, Sholi EH, Demo G, Jami Y, Sha J, et al. The Pseudomonas aeruginosa ribonuclease Ribocin cleaves eukaryotic ribosomes at helix 69 to inhibit host translation. PLOS Biology. 2026. doi:10.1371/journal.pbio.3003790
BibTeX
@article{VasquezRifo2026,
author = {Vasquez-Rifo, Alejandro and Susorov, Denis and Sholi, Emily H and Demo, Gabriel and Jami, Yasaman and Sha, Jihui and Wohlschlegel, James A and Korostelev, Andrei and Ambros, Victor},
title = {The Pseudomonas aeruginosa ribonuclease Ribocin cleaves eukaryotic ribosomes at helix 69 to inhibit host translation},
journal = {PLOS Biology},
year = {2026},
doi = {10.1371/journal.pbio.3003790}
}
EUVIMED